The Pediatric Cardiology Pharmacopeia: 2013 Update

被引：2

作者：

Severin, Paul Nicholas ^{[1
,2
]}

Awad, Sawsan ^{[1
]}

Shields, Beth ^{[1
]}

Hoffman, Joan ^{[1
]}

Bonney, William ^{[3
]}

Cortez, Edmundo ^{[1
,2
]}

Ganesan, Rani ^{[1
,2
]}

Patel, Aloka ^{[1
]}

Barnes, Steve ^{[1
]}

Barnes, Sean ^{[4
]}

Al-Anani, Shada ^{[5
]}

Gupta, Umang ^{[1
]}

Cheddar, Yolandee Bell ^{[1
]}

Gonzalez, Ismael E. ^{[1
]}

Mallula, Kiran ^{[1
]}

Ghawi, Hani ^{[1
]}

Kazmouz, Suhaib ^{[1
]}

Gendi, Salwa ^{[1
]}

Abdulla, Ra-id ^{[1
]}

机构：

[1] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA

[2] John H Stroger Jr Hosp Cook Cty, Chicago, IL 60612 USA

[3] Childrens Hosp Philadelphia, Dept Cardiol, Philadelphia, PA 19104 USA

[4] Johns Hopkins Univ, Combined Pediat & Anesthesiol Residency Program, Baltimore, MD USA

[5] Childrens Hosp Wisconsin, Milwaukee, WI USA

来源：

PEDIATRIC CARDIOLOGY | 2013年 / 34卷 / 01期

关键词：

Congestive heart failure; Pediatric cardiology; Pharmacologic agents; Pharmacopeia; Inotropes; Vasodilators; Antiarrhythmic; Fetal drugs; Anticoagulants; Diuretics; CONGENITAL HEART-BLOCK; INHALED NITRIC-OXIDE; PRIMARY PULMONARY-HYPERTENSION; CARDIAC-SURGERY; AEROSOLIZED PROSTACYCLIN; ATRIOVENTRICULAR-BLOCK; INFECTIVE ENDOCARDITIS; FETAL TACHYARRHYTHMIAS; AMERICAN-COLLEGE; MANAGEMENT;

D O I：

10.1007/s00246-012-0553-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.

引用

页码：1 / 29

页数：29

共 50 条

[21] Stem cells in pediatric cardiology
Patel, Pranali
Mital, Seema
EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (10) : 1287 - 1292
[22] Upcoming Events in Pediatric Cardiology
Pediatric Cardiology, 2006, 27 (5) : 660 - 660
[23] Board Certification in Pediatric Cardiology
Ra-id Abdulla
Pediatric Cardiology, 2005, 26 : 309 - 310
[24] Stem cells in pediatric cardiology
Pranali Patel
Seema Mital
European Journal of Pediatrics, 2013, 172 : 1287 - 1292
[25] Editorial: Controversies in Pediatric Cardiology
Corno, Antonio F.
Crossland, David S.
FRONTIERS IN PEDIATRICS, 2020, 8
[26] Pediatric Cardiology: A Monthly Publication
Ra-id Abdulla
Pediatric Cardiology, 2009, 30 : 1 - 2
[27] Board certification in pediatric cardiology
Abdulla, RI
PEDIATRIC CARDIOLOGY, 2005, 26 (04) : 309 - 310
[28] Upcoming Events in Pediatric Cardiology
Pediatric Cardiology, 2006, 27 (4) : 530 - 530
[29] PEDIATRIC CARDIOLOGY - PAST AND PRESENT
LINDINGER, A
MEDIZINISCHE WELT, 1991, 42 (02): : 107 - 115
[30] Telehealth for Pediatric Cardiology Practitioners in the Time of COVID-19
Chowdhury, Devyani
Hope, Kyle D.
Arthur, Lindsay C.
Weinberger, Sharon M.
Ronai, Christina
Johnson, Jonathan N.
Snyder, Christopher S.
PEDIATRIC CARDIOLOGY, 2020, 41 (06) : 1081 - 1091

← 1 2 3 4 5 →